Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (501-510 of 568) with videos related to

Pageof 57
Sort By:
Journal of Crohn'S & Colitis|September 24, 2020
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA RegistryMaría Chaparro, Ana Garre, Francisco Mesonero, et al.
Journal of Crohn'S & Colitis|June 15, 2024
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Silvia Minozzi, Janindra Warusavitarne, et al.
Journal of Crohn'S & Colitis|July 1, 2026
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical TreatmentMichel Adamina, Peter Kienle, María Chaparro, et al.
Gut|September 22, 2020
European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patientsOlga P Nyssen, Dmitry Bordin, Bojan Tepes, et al.
Frontiers in Cellular and Infection Microbiology|July 16, 2025
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomicsMacarena Orejudo, Manuel J Gómez, Sabino Riestra, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2024
Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort studyPatricia Sanz Segura, Fernando Gomollón, Diego Casas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitisGiuseppe Privitera, Cristina Bezzio, Gisella Figlioli, et al.
Journal of Crohn'S & Colitis|October 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionIdan Goren, Ortal Fallek Boldes, Tomer Boldes, et al.
Journal of Clinical Medicine|July 9, 2022
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCUSabino Riestra, Carlos Taxonera, Yamile Zabana, et al.
Inflammatory Bowel Diseases|August 3, 2023
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease PatientsLaila Aldars-García, Rubén Gil-Redondo, Nieves Embade, et al.
Pageof 57

Showing results (501-510 of 568) with videos related to

Sort By:
Pageof 57
Journal of Crohn'S & Colitis|September 24, 2020
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA RegistryMaría Chaparro, Ana Garre, Francisco Mesonero, et al.
Journal of Crohn'S & Colitis|June 15, 2024
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Silvia Minozzi, Janindra Warusavitarne, et al.
Journal of Crohn'S & Colitis|July 1, 2026
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical TreatmentMichel Adamina, Peter Kienle, María Chaparro, et al.
Gut|September 22, 2020
European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patientsOlga P Nyssen, Dmitry Bordin, Bojan Tepes, et al.
Frontiers in Cellular and Infection Microbiology|July 16, 2025
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomicsMacarena Orejudo, Manuel J Gómez, Sabino Riestra, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2024
Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort studyPatricia Sanz Segura, Fernando Gomollón, Diego Casas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitisGiuseppe Privitera, Cristina Bezzio, Gisella Figlioli, et al.
Journal of Crohn'S & Colitis|October 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionIdan Goren, Ortal Fallek Boldes, Tomer Boldes, et al.
Journal of Clinical Medicine|July 9, 2022
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCUSabino Riestra, Carlos Taxonera, Yamile Zabana, et al.
Inflammatory Bowel Diseases|August 3, 2023
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease PatientsLaila Aldars-García, Rubén Gil-Redondo, Nieves Embade, et al.
Pageof 57